MedicinesFAQ

Covid-19 Vaccine Novavax Uses, Dosage, Side Effects and more

Covid-19 Vaccine Novavax is a SARS-CoV-2 rS vaccine candidate and was shown to have high immunogenicity in studies. The vaccine is created from the genetic sequence of COVID-19 and the antigen derived from the virus spike protein is generated using recombinant nanoparticle technology. The vaccine was developed and tested by Novavax. As of May 2020, the company is pursuing a Phase 1 clinical trial (NCT04368988) to test the vaccine.

Attribute Details
Trade Name Covid-19 Vaccine Novavax
Generic NVX-CoV2373
NVX-CoV2373 Other Names SARS-CoV-2 rS Nanoparticle Vaccine
Type Injection, suspension
Groups Investigational
Therapeutic Class
Manufacturer
Available Country United States
Last Updated: January 7, 2025 at 1:49 am
   

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.